AR095206A1 - ACCELULAR VACCINE AGAINST PERTUSSIS - Google Patents
ACCELULAR VACCINE AGAINST PERTUSSISInfo
- Publication number
- AR095206A1 AR095206A1 ARP140100814A ARP140100814A AR095206A1 AR 095206 A1 AR095206 A1 AR 095206A1 AR P140100814 A ARP140100814 A AR P140100814A AR P140100814 A ARP140100814 A AR P140100814A AR 095206 A1 AR095206 A1 AR 095206A1
- Authority
- AR
- Argentina
- Prior art keywords
- pertussis
- composition according
- accelular
- toxoid
- vaccine against
- Prior art date
Links
- 201000005702 Pertussis Diseases 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 108010021711 pertactin Proteins 0.000 abstract 4
- 101710154643 Filamentous hemagglutinin Proteins 0.000 abstract 2
- 241000588832 Bordetella pertussis Species 0.000 abstract 1
- 239000002671 adjuvant Substances 0.000 abstract 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 abstract 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 229960003983 diphtheria toxoid Drugs 0.000 abstract 1
- 229960000814 tetanus toxoid Drugs 0.000 abstract 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Una composición de vacuna acelular contra pertussis (aP) que comprende los antígenos para Bordetella pertussis de toxoide de pertussis (PT), de hemaglutinina filamentosa (FHA) y las fimbrias tipos 2 y 3 (FIM), y opcionalmente pertactina (PRN), donde FIM está presente en una cantidad de 12 - 100 mg por dosis para humanos. Reivindicación 6: Una composición de vacuna aP de acuerdo con cualquiera de las reivindicaciones precedentes, caracterizada porque además comprende pertactina (PRN). Reivindicación 9: Una composición de acuerdo con la reivindicación 8, caracterizada porque comprende el toxoide del tétano y el toxoide de la difteria. Reivindicación 12: Una composición de acuerdo con la reivindicación 11, caracterizada porque el adyuvante comprende hidróxido de aluminio, fosfato de aluminio o una combinación de los mismos.An acellular pertussis (aP) vaccine composition comprising antigens for Bordetella pertussis of pertussis toxoid (PT), filamentous hemagglutinin (FHA) and fimbriae types 2 and 3 (FIM), and optionally pertactin (PRN), where FIM is present in an amount of 12-100 mg per dose for humans. Claim 6: An aP vaccine composition according to any of the preceding claims, characterized in that it further comprises pertactin (PRN). Claim 9: A composition according to claim 8, characterized in that it comprises tetanus toxoid and diphtheria toxoid. Claim 12: A composition according to claim 11, characterized in that the adjuvant comprises aluminum hydroxide, aluminum phosphate or a combination thereof.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361774993P | 2013-03-08 | 2013-03-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR095206A1 true AR095206A1 (en) | 2015-09-30 |
Family
ID=56119030
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP140100814A AR095206A1 (en) | 2013-03-08 | 2014-03-10 | ACCELULAR VACCINE AGAINST PERTUSSIS |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR095206A1 (en) |
-
2014
- 2014-03-10 AR ARP140100814A patent/AR095206A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20151720A1 (en) | ACELLULAR VACCINE AGAINST PERTUSSIS | |
| CL2019003264A1 (en) | Formulations for vaccines against neoplasia and methods for preparing the same. (divisional request 201703151) | |
| CR11122A (en) | WATER OIL EMULSION INFLUENZA VACCINE | |
| PE20151588A1 (en) | VACCINE AGAINST DENGUE VIRUS | |
| MX2023000211A (en) | Vaccine compositions having improved stability and immunogenicity. | |
| CL2016000650A1 (en) | Vaccine composition comprising an antigen and an adjuvant formulation, comprising at least 50% v / v of an oil phase, monophosphoryl lipid a (mpl-a) or an analog thereof and an immunostimulate oligonucleotide; and use of the vaccine composition to prepare a medicament. | |
| CO6160334A2 (en) | METHOD FOR THE ELABORATION OF A CONBINATION VACCINE TO PROTECT AGAINST POLIO | |
| BR112015005056A2 (en) | combination vaccines with meningococcus serogroup b and d / t / p | |
| MX2022002106A (en) | Single vial vaccine formulations. | |
| CL2015001111A1 (en) | Adjuvant composition comprising a carbohydrate attached to the chitosan forming a schiff base; vaccine formulation that comprises it; elaboration method; and use of the vaccine. | |
| AR108829A1 (en) | VACCINE AGAINST INFECTIOUS BRONCHITIS VIRUS | |
| CO6361948A2 (en) | USE OF MYCOPLASMA BOVIS ANTIGEN | |
| MX2016016746A (en) | Dual adjuvant vaccine compositions, preparation and uses. | |
| MX2023012390A (en) | Vaccination with replicon particles and oil adjuvant. | |
| MX2016013299A (en) | VACCINE COMPOSITIONS. | |
| BR112019003992A2 (en) | neisseria meningitidis vaccine | |
| CL2013002219A1 (en) | Immunogenic composition comprising bordetella bronchiseptica and an isolated pertactin antigen; and its use to treat or prevent infection by a canine respiratory pathogen in a dog. | |
| PL404247A1 (en) | LOS oligosugar Bordetella pertussis and pertussis toxin and its use in the prevention and treatment of infections caused by Bordetella pertussis | |
| MX2017006744A (en) | ADJUTIVE COMPOSITIONS AND RELATED METHODS. | |
| BR112012014689A2 (en) | vaccine composition | |
| AR095206A1 (en) | ACCELULAR VACCINE AGAINST PERTUSSIS | |
| AR090538A1 (en) | VACCINE FOR THE PREVENTION OF INFECTIONS WITH BORDETELLA | |
| AR106501A1 (en) | VACCINE ADJUSTER AND COMPOSITION CONTAINING IT | |
| MX2020006061A (en) | A VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS. | |
| MX2022000525A (en) | VACCINES AGAINST EHRLICHIA AND IMMUNOGENIC COMPOSITIONS. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |